Trials / Terminated
TerminatedNCT00089557
An Open-Label Extension Study of NGX-4010 for the Treatment of Neuropathic Pain
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- NeurogesX · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is an open-label, multicenter, extension study for subjects who completed NeurogesX Study C111 and received treatment with NGX-4010 (Capsaicin Patch) within 12 weeks (up to +7days) before entry into Study C114
Conditions
- Herpes Zoster
- Neuralgia
- Pain
- HIV Infections
- Peripheral Nervous System Diseases
- Diabetic Neuropathies
- Diabetes Mellitus
- Polyneuropathies
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Capsaicin Dermal Patch |
Timeline
- First posted
- 2004-08-09
- Last updated
- 2005-06-24
Source: ClinicalTrials.gov record NCT00089557. Inclusion in this directory is not an endorsement.